1. Jian W, Danhua Y, Lei Z, Yuhua H. Chronic intestinal radioactive damnification surgery expert consensus (2019 edition). Chin J Pract Surg. 2019:33(4):307-11.
2. Wang L, Wang J. Chinese consensus on diagnosis and treatment of radiation proctitis (2018). Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(12):1321-36 (in Chinese).
3. Gami B, Harrington K, Blake P, et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther. 2003;18(10):987-94. DOI:10.1046/j.1365-2036.2003.01760.x
4. Сычева И.В. Лечение лучевых повреждений органов малого таза после лучевой терапии рака предстательной железы. Сибирский онкологический журнал. 2018;17(3):64-71 [Sycheva IV. Treatment of radiation-induced pelvic damage after radiation therapy for prostate cancer. Siberian Journal of Oncology. 2018;17(3):64-71 (in Russian)]. DOI:10.21294/1814-4861-2018-17-3-64-71
5. Andreyev HJ, Davidson SE, Gillespie C, et al. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut. 2012;61(2):179-92. DOI:10.1136/gutjnl-2011-300563
6. Парфенов А.И. Энтерология: руководство для врачей. 2-е изд. М.: МИА, 2009 [Parfenov AI. Enterologiia: rukovodstvo dlia vrachei. 2-e izd. Moscow: MIA, 2009 (in Russian)].
7. Парфенов А.И. Современные подходы к диагностике и лечению энтеропатий. Терапевтический архив. 2014;86(2):4-12 [Parfenov AI. Current approaches to the diagnosis and treatment for enteropathies. Terapevticheskii Arkhiv (Ter. Arkh.). 2014;86(2):4-12 (in Russian)].
8. Lakkis Z, Manceau G, Bridoux V, et al. Management of rectal cancer: the 2016 French guidelines. Colorectal Dis. 2017;19(2):115-22. DOI:10.1111/codi.13550
9. Rozet F, Hennequin C, Beauval JB, et al. RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020: cancer de la prostate French ccAFU guidelines – Update 2018–2020: Prostate cancer. Prog Urol. 2018;28(12S):79-130 (in French). DOI:10.1016/j.purol.2018.08.011
10. Herold DM, Hanlon AL, Hanks GE. Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys. 1999;43(3):475-9. DOI:10.1016/s0360-3016(98)00460-x
11. Willett CG, Ooi CJ, Zietman AL, et al. Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. Int J Radiat Oncol Biol Phys. 2000;46(4):995-8. DOI:10.1016/s0360-3016(99)00374-0
12. Eifel PJ, Jhingran A, Bodurka DC, et al. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002;20(17):3651-7. DOI:10.1200/JCO.2002.10.128
13. Vale CL, Tierney JF, Davidson SE, et al. Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists' audit. Clin Oncol (R Coll Radiol). 2010;22(7):590-601. DOI:10.1016/j.clon.2010.06.002
14. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(15):1154-61. DOI:10.1056/NEJM199904153401503
15. Huang EY, Sung CC, Ko SF, et al. The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: a prospective study with computed tomography-based dosimetry. Int J Radiat Oncol Biol Phys. 2007;69(3):732-9. DOI:10.1016/j.ijrobp.2007.03.060
16. Kim TG, Park B, Song YG, et al. Patient-related risk factors for late rectal bleeding after hypofractionated radiotherapy for localized prostate cancer: a single-center retrospective study. Radiat Oncol. 2022;17(1):30. DOI:10.1186/s13014-022-01998-4
17. Yang TJ, Oh JH, Son CH, et al. Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer. Gastrointest Cancer Res. 2013;6(5-6):129-36.
18. Spampinato S, Jensen NBK, Pötter R, et al. Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future. Int J Radiat Oncol Biol Phys. 2022;112(3):681-93. DOI:10.1016/j.ijrobp.2021.09.055
19. Бардычев М.С., Цыб А.Ф. Местные лучевые повреждения. М.: Медицина, 1985 [Bardychev MS, Tsyb AF. Mestnye luchevye povrezhdeniia. Moscow: Meditsina, 1985 (in Russian)].
20. Бардычев М.С. Лучевые повреждения. В: Лучевая терапия злокачественных новообразований. Под ред. Е.С. Киселевой. М.: Медицина, 1996 [Bardychev MS. Luchevye povrezhdeniia. In: Luchevaia terapiia zlokachestvennykh novoobrazovanii. Pod red. E.S. Kiselevoi. Moscow: Meditsina, 1996 (in Russian)].
21. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys. 1995;31(5):1049-91. DOI:10.1016/0360-3016(95)90159-0
22. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341-6. DOI:10.1016/0360-3016(95)00060-C
23. Zinicola R, Rutter MD, Falasco G, et al. Haemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapy. Int J Colorectal Dis. 2003;18(5):439-44. DOI:10.1007/s00384-003-0487-y
24. Sherman LF. A reevaluation of the factitial proctitis problem. Am J Surg. 1954;88(5):773-9. DOI:10.1016/0002-9610(54)90274-3
25. Wachter S, Gerstner N, Goldner G, et al. Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma. Radiother Oncol. 2000;54(1):11-9. DOI:10.1016/s0167-8140(99)00173-5
26. Гришина Е.А., Леонтьев А.В., Шишин К.В., Данилов М.А. Методы лечения пациентов с хроническим лучевым проктитом при помощи эндоскопических технологий. Хирургическая практика. 2023;8(3):6-18 [Grishina EA, Leontev AV, Shishin KV, Danilov MA. Methods of endoscopic treatment of chronic radiation proctitis. Surgical Practice (Russia). 2023;8(3):6-18 (in Russian)]. DOI:10.38181/2223-2427-2023-3-1
27. Леонтьев А.В., Гришина Е.А., Шишин К.В., и др. Применение эндоскопической радиочастотной абляции в лечении хронического лучевого проктита: опыт МКНЦ им. А.С. Логинова. Эндоскопическая хирургия. 2022;28(1):20-5 [Leontiev AV, Grishina EA, Shishin KV, et al. Endoscopic radiofrequency ablation for chronic radiation proctitis treatment: Loginov Moscow Clinical Scientific Center experience. Endoscopic Surgery. 2022;28(1):20-5 (in Russian)]. DOI:10.17116/endoskop20222801120
28. West CM, Barnett GC. Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med. 2011;3(8):52. DOI:10.1186/gm268
29. Morris KA, Haboubi NY. Pelvic radiation therapy: Between delight and disaster. World J Gastrointest Surg. 2015;7(11):279-88. DOI:10.4240/wjgs.v7.i11.279
30. Haboubi NY, El-Zammar O, O'Dwyer ST, James RJ. Radiation bowel disease: pathogenesis and management. Colorectal Dis. 2000;2(6):322-9. DOI:10.1046/j.1463-1318.2000.00184.x
31. Metheetrairut C, Slack FJ. MicroRNAs in the ionizing radiation response and in radiotherapy. Curr Opin Genet Dev. 2013;23(1):12-9. DOI:10.1016/j.gde.2013.01.002
32. Hauer-Jensen M, Denham JW, Andreyev HJ. Radiation enteropathy –pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol. 2014;11(8):470-9. DOI:10.1038/nrgastro.2014.46
33. Husebye E, Hauer-Jensen M, Kjørstad K, Skar V. Severe late radiation enteropathy is characterized by impaired motility of proximal small intestine. Dig Dis Sci. 1994;39(11):2341-9. DOI:10.1007/BF02087648
34. Bourne RG, Kearsley JH, Grove WD, Roberts SJ. The relationship between early and late gastrointestinal complications of radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1983;9(10):1445-50. DOI:10.1016/0360-3016(83)90316-4
35. Peters LJ, Ang KK, Thames HD Jr. Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol. 1988;27(2):185-94. DOI:10.3109/02841868809090339
36. Barazzuol L, Coppes RP, van Luijk P. Prevention and treatment of radiotherapy-induced side effects. Mol Oncol. 2020;14(7):1538-54. DOI:10.1002/1878-0261.12750
37. Zimmerer T, Böcker U, Wenz F, Singer MV. Medical prevention and treatment of acute and chronic radiation induced enteritis – is there any proven therapy? a short review. Z Gastroenterol. 2008;46(5):441-8. DOI:10.1055/s-2008-1027150
38. Ren H, Wu Q, Sun Z, et al. Research progress and treatment of radiation enteritis and gut microbiota. Radiat Oncol J. 2023;41(2):61-8. DOI:10.3857/roj.2023.00346
39. Jiang HH, Li XF, Wang JL. Relationship between chronic radiation enteritis of cervical cancer and gut microbiota. Beijing Da Xue Xue Bao Yi Xue Ban. 2023;55(4):619-24 (in Chinese). DOI:10.19723/j.issn.1671-167X.2023.04.008
40. Rothschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210-1. DOI:10.1038/nature25973
41. Shaw L, Ribeiro ALR, Levine AP, et al. The Human Salivary Microbiome Is Shaped by Shared Environment Rather than Genetics: Evidence from a Large Family of Closely Related Individuals. mBio. 2017;8(5). DOI:10.1128/mBio.01237-17
42. Loge L, Florescu C, Alves A, Menahem B. Radiation enteritis: Diagnostic and therapeutic issues. J Visc Surg. 2020;157(6):475-85. DOI:10.1016/j.jviscsurg.2020.08.012
43. Haboubi N. Pathology and pathogenesis of radiation bowel disease: histopathological appraisal in the clinical setting. EMJ Gastroenterol. 2018;7(1):113-9. DOI:10.33590/emjgastroenterol/10312807
44. Bondeven P, Emmertsen KJ, Laurberg S, Pedersen BG. Neoadjuvant therapy abolishes the functional benefits of a larger rectal remnant, as measured by magnetic resonance imaging after restorative rectal cancer surgery. Eur J Surg Oncol. 2015;41(11):1493-9. DOI:10.1016/j.ejso.2015.07.003
45. Bregendahl S, Emmertsen KJ, Lous J, Laurberg S. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Colorectal Dis. 2013;15(9):1130-9. DOI:10.1111/codi.12244
46. Kuku S, Fragkos C, McCormack M, Forbes A. Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers. Br J Cancer. 2013;109(6):1504-12. DOI:10.1038/bjc.2013.491
47. Putta S, Andreyev HJ. Faecal incontinence: A late side-effect of pelvic radiotherapy. Clin Oncol (R Coll Radiol). 2005;17(6):469-77. DOI:10.1016/j.clon.2005.02.008
48. Haboubi NY, Schofield PF, Rowland PL. The light and electron microscopic features of early and late phase radiation-induced proctitis. Am J Gastroenterol. 1988;83(10):1140-4.
49. Do NL, Nagle D, Poylin VY. Radiation proctitis: current strategies in management. Gastroenterol Res Pract. 2011;2011:917941. DOI:10.1155/2011/917941
50. Berthrong M, Fajardo LF. Radiation injury in surgical pathology. Part II. Alimentary tract. Am J Surg Pathol. 1981;5(2):153-78. DOI:10.1097/00000478-198103000-00006
51. Larsen A, Bjørge B, Klementsen B, et al. Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. Acta Oncol. 2007;46(5):639-50. DOI:10.1080/02841860601099241
52. Haboubi NY, Kaftan SM, Schofield PF. Radiation colitis is another mimic of chronic inflammatory bowel disease. J Clin Pathol. 1992;45(3):272. DOI:10.1136/jcp.45.3.272-a
53. Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol. 2007;8(11):1007-17. DOI:10.1016/S1470-2045(07)70341-8
54. Бурковская В.А. Радиационные (лучевые) поражения кишечника. Гастроэнтерология Санкт-Петербурга. 2013;3-4:18-24 [Burkovskaia VA. Radiatsionnye (luchevye) porazheniia kishechnika. Gastroenterologiia Sankt-Peterburga. 2013;3-4:18-24 (in Russian)].
55. Andreyev HJ, Wotherspoon A, Denham JW, Hauer-Jensen M. “Pelvic radiation disease”: new understanding and new solutions for a new disease in the era of cancer survivorship. Scand J Gastroenterol. 2011;46(4):389-97. DOI:10.3109/00365521.2010.545832
56. Shadad AK, Sullivan FJ, Martin JD, Egan LJ. Gastrointestinal radiation injury: symptoms, risk factors and mechanisms. World J Gastroenterol. 2013;19(2):185-98. DOI:10.3748/wjg.v19.i2.185
57. Leiper K, Morris AI. Treatment of radiation proctitis. Clin Oncol (R Coll Radiol). 2007;19(9):724-9. DOI:10.1016/j.clon.2007.07.008
58. Vanneste BG, Van De Voorde L, de Ridder RJ, et al. Chronic radiation proctitis: tricks to prevent and treat. Int J Colorectal Dis. 2015;30(10):1293-303. DOI:10.1007/s00384-015-2289-4
59. Wu XR, Liu XL, Katz S, Shen B. Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis. Inflamm Bowel Dis. 2015;21(3):703-15. DOI:10.1097/MIB.0000000000000227
60. Gichangi P, Bwayo J, Estambale B, et al. HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer. Gynecol Oncol. 2006;100(2):405-11. DOI:10.1016/j.ygyno.2005.10.006
61. Mendelson RM, Nolan DJ. The radiological features of chronic radiation enteritis. Clin Radiol. 1985;36(2):141-8. DOI:10.1016/s0009-9260(85)80097-0
62. Son JH, Kim SH, Cho EY, Ryu KH. Comparison of diagnostic performance between 1 millisievert CT enterography and half-standard dose CT enterography for evaluating active inflammation in patients with Crohn's disease. Abdom Radiol (NY). 2018;43(7):1558-56. DOI:10.1007/s00261-017-1359-1
63. Algin O, Turkbey B, Ozmen E, Algin E. Magnetic resonance enterography findings of chronic radiation enteritis. Cancer Imaging. 2011;11(1):189-94. DOI:10.1102/1470-7330.2011.0026
64. Porouhan P, Farshchian N, Dayani M. Management of radiation-induced proctitis. J Family Med Prim Care. 2019;8(7):2173-18. DOI:10.4103/jfmpc.jfmpc_333_19
65. Kim HM, Kim YJ, Kim HJ, et al. A pilot study of capsule endoscopy for the diagnosis of radiation enteritis. Hepatogastroenterology. 2011;58(106):459-64.
66. Jazwinski A, Palazzo J, Kastenberg D. Capsule endoscopy diagnosis of radiation enteritis in a patient previously considered to have celiac sprue. Endoscopy. 2007;39(Suppl. 1):E66. DOI:10.1055/s-2006-944715
67. Lee DW, Poon AO, Chan AC. Diagnosis of small bowel radiation enteritis by capsule endoscopy. Hong Kong Med J. 2004;10(6):419-21.
68. Webb GJ, Brooke R, De Silva AN. Chronic radiation enteritis and malnutrition. J Dig Dis. 2013;14(7):350-7. DOI:10.1111/1751-2980.12061
69. Пасов В.В., Курпешева А.К. Осложнения и повреждения органов и тканей при лучевой терапии. В: Основы лучевой диагностики и терапии: национальное руководство. Под ред. С.К. Терновой. М.: ГЭОТАР-Медиа, 2012 [Pasov VV, Kurpesheva AK. Oslozhneniia i povrezhdeniia organov i tkanei pri luchevoi terapii. In: Osnovy luchevoi diagnostiki i terapii: natsional'noe rukovodstvo. Pod red. SK Ternovoi. Moscow: GEOTAR-Media, 2012 (in Russian)].
70. Пасов В.В., Курпешева А.К., Терехов О.В. Местные лучевые повреждения у онкологических больных (консервативное лечение). В: Терапевтическая радиология. Под ред. А.Ф. Цыба, Ю.С. Мардынского. М.: Медицинская книга, 2010 [Pasov VV, Kurpesheva AK, Terekhov OV. Mestnye luchevye povrezhdeniia u onkologicheskikh bol'nykh (konservativnoe lechenie). In: Terapevticheskaia radiologiia. Pod red. AF Tsyba, IuS Mardynskogo. Moscow: Meditsinskaia kniga, 2010 (in Russian)].
71. Kennedy GD, Heise CP. Radiation colitis and proctitis. Clin Colon Rectal Surg. 2007;20(1):64-72. DOI:10.1055/s-2007-970202
72. Ma TH, Yuan ZX, Zhong QH, et al. Formalin irrigation for hemorrhagic chronic radiation proctitis. World J Gastroenterol. 2015;21(12):3593-8. DOI:10.3748/wjg.v21.i12.3593
73. Manojlovic N, Babic D. Radiation-induced rectal ulcer – prognostic factors and medical treatment. Hepatogastroenterology. 2004;51(56):447-50.
74. Chun M, Kang S, Kil HJ, et al. Rectal bleeding and its management after irradiation for uterine cervical cancer. Int J Radiat Oncol Biol Phys. 2004;58(1):98-105. DOI:10.1016/s0360-3016(03)01395-6
75. Kochhar R, Patel F, Dhar A, et al. Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci. 1991;36(1):103-7. DOI:10.1007/BF01300096
76. Топчий Т.Б., Сычева И.В., Рухадзе Г.О., и др. Лучевые проктиты: пособие для врачей. М.: Прима Принт, 2019 [Topchii TB, Sycheva IV, Rukhadze GO, et al. Luchevye proktity: posobie dlia vrachei. Moscow: Prima Print, 2019 (in Russian)].
77. Demers M, Dagnault A, Desjardins J. A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin Nutr. 2014;33(5):761-7. DOI:10.1016/j.clnu.2013.10.015
78. Cui M, Xiao H, Li Y, et al. Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med. 2017;9(4):448-61. DOI:10.15252/emmm.201606932
79. Thackham JA, McElwain DL, Long RJ. The use of hyperbaric oxygen therapy to treat chronic wounds: A review. Wound Repair Regen. 2008;16(3):321-30. DOI:10.1111/j.1524-475X.2008.00372.x
80. Pasquier D, Hoelscher T, Schmutz J, et al. Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: a literature review. Radiother Oncol. 2004;72(1):1-13. DOI:10.1016/j.radonc.2004.04.005
81. Dalsania RM, Shah KP, Stotsky-Himelfarb E, et al. Management of Long-Term Toxicity From Pelvic Radiation Therapy. Am Soc Clin Oncol Educ Book. 2021;41:1-11. DOI:10.1200/EDBK_323525
82. Yang XF, Zheng MY, An LY, et al. Quality evaluation of guidelines for the diagnosis and treatment of radiation enteritis. Radiat Oncol. 2023;18(1):14. DOI:10.1186/s13014-023-02204-9
83. Girvent M, Carlson GL, Anderson I, et al. Intestinal failure after surgery for complicated radiation enteritis. Ann R Coll Surg Engl. 2000;82(3):198-201.
84. Regimbeau JM, Panis Y, Gouzi JL, et al. Operative and long term results after surgery for chronic radiation enteritis. Am J Surg. 2001;182(3):237-42. DOI:10.1016/s0002-9610(01)00705-x
85. Onodera H, Nagayama S, Mori A, et al. Reappraisal of surgical treatment for radiation enteritis. World J Surg. 2005;29(4):459-63. DOI:10.1007/s00268-004-7699-3
86. Lefevre JH, Amiot A, Joly F, et al. Risk of recurrence after surgery for chronic radiation enteritis. Br J Surg. 2011;98(12):1792-7. DOI:10.1002/bjs.7655
87. Wilmore DW, Robinson MK. Short bowel syndrome. World J Surg. 2000;24(12):1486-92. DOI:10.1007/s002680010266
88. Donohoe CL, Reynolds JV. Short bowel syndrome. Surgeon. 2010;8(5):270-9. DOI:10.1016/j.surge.2010.06.004
89. Nightingale J. Intestinal failure and short bowel syndrome. Medicine. 1998;26:114-6. DOI:10.1051/medsci/2021110
90. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124(4):1111-34. DOI:10.1016/s0016-5085(03)70064-x
91. Jang H, Park S, Lee J, et al. Rebamipide alleviates radiation-induced colitis through improvement of goblet cell differentiation in mice. J Gastroenterol Hepatol. 2018;33(4):878-86. DOI:10.1111/jgh.14021
92. Звяглова М.Ю., Князев О.В., Парфенов А.И. Фармакологический и клинический профиль ребамипида: новые терапевтические мишени. Терапевтический архив. 2020;92(2):104-11 [Zvyaglova MYu, Knyazev OV, Parfenov AI. Pharmacological and clinical feature of rebamipide: new therapeutic targets. Terapevticheskii Arkhiv (Ter. Arkh.). 2020;92(2):104-11 (in Russian)]. DOI:10.26442/00403660.2020.02.000569
93. Симаненков В.И., Маев И.В., Ткачева О.Н., и др. Синдром повышенной эпителиальной проницаемости в клинической практике. Мультидисциплинарный национальный консенсус. Кардиоваскулярная терапия и профилактика. 2021;20(1):2758 [Simanenkov VI, Maev IV, Tkacheva ON, et al. Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus. Cardiovascular Therapy and Prevention. 2021;20(1):2758 (in Russian)]. DOI:10.15829/1728-8800-2021-2758
94. Jang H, Lee J, Park S, et al. Pravastatin Attenuates Acute Radiation-Induced Enteropathy and Improves Epithelial Cell Function. Front Pharmacol. 2018;9:1215. DOI:10.3389/fphar.2018.01215
95. Jang H, Kim S, Kim H, et al. Metformin Protects the Intestinal Barrier by Activating Goblet Cell Maturation and Epithelial Proliferation in Radiation-Induced Enteropathy. Int J Mol Sci. 2022;23(11):5929. DOI:10.3390/ijms23115929
96. Yang JY, Liu MJ, Lv L, et al. Metformin alleviates irradiation-induced intestinal injury by activation of FXR in intestinal epithelia. Front Microbiol. 2022;13:932294. DOI:10.3389/fmicb.2022.932294
97. Nutting CM, Convery DJ, Cosgrove VP, et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2000;48(3):649-56. DOI:10.1016/s0360-3016(00)00653-2
98 Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001;51(1):261-6. DOI:10.1016/s0360-3016(01)01664-9
99. Lawrie TA, Green JT, Beresford M, et al. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. Cochrane Database Syst Rev. 2018;1(1):CD012529. DOI:10.1002/14651858
100. Theis VS, Sripadam R, Ramani V, Lal S. Chronic radiation enteritis. Clin Oncol (R Coll Radiol). 2010;22(1):70-83. DOI:10.1016/j.clon.2009.10.003

________________________________________________

1. Jian W, Danhua Y, Lei Z, Yuhua H. Chronic intestinal radioactive damnification surgery expert consensus (2019 edition). Chin J Pract Surg. 2019:33(4):307-11.
2. Wang L, Wang J. Chinese consensus on diagnosis and treatment of radiation proctitis (2018). Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(12):1321-36 (in Chinese).
3. Gami B, Harrington K, Blake P, et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther. 2003;18(10):987-94. DOI:10.1046/j.1365-2036.2003.01760.x
4. Sycheva IV. Treatment of radiation-induced pelvic damage after radiation therapy for prostate cancer. Siberian Journal of Oncology. 2018;17(3):64-71 (in Russian). DOI:10.21294/1814-4861-2018-17-3-64-71
5. Andreyev HJ, Davidson SE, Gillespie C, et al. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut. 2012;61(2):179-92. DOI:10.1136/gutjnl-2011-300563
6. Parfenov AI. Enterologiia: rukovodstvo dlia vrachei. 2-e izd. Moscow: MIA, 2009 (in Russian).
7. Parfenov AI. Current approaches to the diagnosis and treatment for enteropathies. Terapevticheskii Arkhiv (Ter. Arkh.). 2014;86(2):4-12 (in Russian).
8. Lakkis Z, Manceau G, Bridoux V, et al. Management of rectal cancer: the 2016 French guidelines. Colorectal Dis. 2017;19(2):115-22. DOI:10.1111/codi.13550
9. Rozet F, Hennequin C, Beauval JB, et al. RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020: cancer de la prostate French ccAFU guidelines – Update 2018–2020: Prostate cancer. Prog Urol. 2018;28(12S):79-130 (in French). DOI:10.1016/j.purol.2018.08.011
10. Herold DM, Hanlon AL, Hanks GE. Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys. 1999;43(3):475-9. DOI:10.1016/s0360-3016(98)00460-x
11. Willett CG, Ooi CJ, Zietman AL, et al. Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. Int J Radiat Oncol Biol Phys. 2000;46(4):995-8. DOI:10.1016/s0360-3016(99)00374-0
12. Eifel PJ, Jhingran A, Bodurka DC, et al. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002;20(17):3651-7. DOI:10.1200/JCO.2002.10.128
13. Vale CL, Tierney JF, Davidson SE, et al. Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists' audit. Clin Oncol (R Coll Radiol). 2010;22(7):590-601. DOI:10.1016/j.clon.2010.06.002
14. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(15):1154-61. DOI:10.1056/NEJM199904153401503
15. Huang EY, Sung CC, Ko SF, et al. The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: a prospective study with computed tomography-based dosimetry. Int J Radiat Oncol Biol Phys. 2007;69(3):732-9. DOI:10.1016/j.ijrobp.2007.03.060
16. Kim TG, Park B, Song YG, et al. Patient-related risk factors for late rectal bleeding after hypofractionated radiotherapy for localized prostate cancer: a single-center retrospective study. Radiat Oncol. 2022;17(1):30. DOI:10.1186/s13014-022-01998-4
17. Yang TJ, Oh JH, Son CH, et al. Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer. Gastrointest Cancer Res. 2013;6(5-6):129-36.
18. Spampinato S, Jensen NBK, Pötter R, et al. Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future. Int J Radiat Oncol Biol Phys. 2022;112(3):681-93. DOI:10.1016/j.ijrobp.2021.09.055
19. Bardychev MS, Tsyb AF. Mestnye luchevye povrezhdeniia. Moscow: Meditsina, 1985 (in Russian).
20. Bardychev MS. Luchevye povrezhdeniia. In: Luchevaia terapiia zlokachestvennykh novoobrazovanii. Pod red. E.S. Kiselevoi. Moscow: Meditsina, 1996 (in Russian).
21. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys. 1995;31(5):1049-91. DOI:10.1016/0360-3016(95)90159-0
22. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341-6. DOI:10.1016/0360-3016(95)00060-C
23. Zinicola R, Rutter MD, Falasco G, et al. Haemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapy. Int J Colorectal Dis. 2003;18(5):439-44. DOI:10.1007/s00384-003-0487-y
24. Sherman LF. A reevaluation of the factitial proctitis problem. Am J Surg. 1954;88(5):773-9. DOI:10.1016/0002-9610(54)90274-3
25. Wachter S, Gerstner N, Goldner G, et al. Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma. Radiother Oncol. 2000;54(1):11-9. DOI:10.1016/s0167-8140(99)00173-5
26. Grishina EA, Leontev AV, Shishin KV, Danilov MA. Methods of endoscopic treatment of chronic radiation proctitis. Surgical Practice (Russia). 2023;8(3):6-18 (in Russian). DOI:10.38181/2223-2427-2023-3-1
27. Leontiev AV, Grishina EA, Shishin KV, et al. Endoscopic radiofrequency ablation for chronic radiation proctitis treatment: Loginov Moscow Clinical Scientific Center experience. Endoscopic Surgery. 2022;28(1):20-5 (in Russian). DOI:10.17116/endoskop20222801120
28. West CM, Barnett GC. Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med. 2011;3(8):52. DOI:10.1186/gm268
29. Morris KA, Haboubi NY. Pelvic radiation therapy: Between delight and disaster. World J Gastrointest Surg. 2015;7(11):279-88. DOI:10.4240/wjgs.v7.i11.279
30. Haboubi NY, El-Zammar O, O'Dwyer ST, James RJ. Radiation bowel disease: pathogenesis and management. Colorectal Dis. 2000;2(6):322-9. DOI:10.1046/j.1463-1318.2000.00184.x
31. Metheetrairut C, Slack FJ. MicroRNAs in the ionizing radiation response and in radiotherapy. Curr Opin Genet Dev. 2013;23(1):12-9. DOI:10.1016/j.gde.2013.01.002
32. Hauer-Jensen M, Denham JW, Andreyev HJ. Radiation enteropathy –pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol. 2014;11(8):470-9. DOI:10.1038/nrgastro.2014.46
33. Husebye E, Hauer-Jensen M, Kjørstad K, Skar V. Severe late radiation enteropathy is characterized by impaired motility of proximal small intestine. Dig Dis Sci. 1994;39(11):2341-9. DOI:10.1007/BF02087648
34. Bourne RG, Kearsley JH, Grove WD, Roberts SJ. The relationship between early and late gastrointestinal complications of radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1983;9(10):1445-50. DOI:10.1016/0360-3016(83)90316-4
35. Peters LJ, Ang KK, Thames HD Jr. Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol. 1988;27(2):185-94. DOI:10.3109/02841868809090339
36. Barazzuol L, Coppes RP, van Luijk P. Prevention and treatment of radiotherapy-induced side effects. Mol Oncol. 2020;14(7):1538-54. DOI:10.1002/1878-0261.12750
37. Zimmerer T, Böcker U, Wenz F, Singer MV. Medical prevention and treatment of acute and chronic radiation induced enteritis – is there any proven therapy? a short review. Z Gastroenterol. 2008;46(5):441-8. DOI:10.1055/s-2008-1027150
38. Ren H, Wu Q, Sun Z, et al. Research progress and treatment of radiation enteritis and gut microbiota. Radiat Oncol J. 2023;41(2):61-8. DOI:10.3857/roj.2023.00346
39. Jiang HH, Li XF, Wang JL. Relationship between chronic radiation enteritis of cervical cancer and gut microbiota. Beijing Da Xue Xue Bao Yi Xue Ban. 2023;55(4):619-24 (in Chinese). DOI:10.19723/j.issn.1671-167X.2023.04.008
40. Rothschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210-1. DOI:10.1038/nature25973
41. Shaw L, Ribeiro ALR, Levine AP, et al. The Human Salivary Microbiome Is Shaped by Shared Environment Rather than Genetics: Evidence from a Large Family of Closely Related Individuals. mBio. 2017;8(5). DOI:10.1128/mBio.01237-17
42. Loge L, Florescu C, Alves A, Menahem B. Radiation enteritis: Diagnostic and therapeutic issues. J Visc Surg. 2020;157(6):475-85. DOI:10.1016/j.jviscsurg.2020.08.012
43. Haboubi N. Pathology and pathogenesis of radiation bowel disease: histopathological appraisal in the clinical setting. EMJ Gastroenterol. 2018;7(1):113-9. DOI:10.33590/emjgastroenterol/10312807
44. Bondeven P, Emmertsen KJ, Laurberg S, Pedersen BG. Neoadjuvant therapy abolishes the functional benefits of a larger rectal remnant, as measured by magnetic resonance imaging after restorative rectal cancer surgery. Eur J Surg Oncol. 2015;41(11):1493-9. DOI:10.1016/j.ejso.2015.07.003
45. Bregendahl S, Emmertsen KJ, Lous J, Laurberg S. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Colorectal Dis. 2013;15(9):1130-9. DOI:10.1111/codi.12244
46. Kuku S, Fragkos C, McCormack M, Forbes A. Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers. Br J Cancer. 2013;109(6):1504-12. DOI:10.1038/bjc.2013.491
47. Putta S, Andreyev HJ. Faecal incontinence: A late side-effect of pelvic radiotherapy. Clin Oncol (R Coll Radiol). 2005;17(6):469-77. DOI:10.1016/j.clon.2005.02.008
48. Haboubi NY, Schofield PF, Rowland PL. The light and electron microscopic features of early and late phase radiation-induced proctitis. Am J Gastroenterol. 1988;83(10):1140-4.
49. Do NL, Nagle D, Poylin VY. Radiation proctitis: current strategies in management. Gastroenterol Res Pract. 2011;2011:917941. DOI:10.1155/2011/917941
50. Berthrong M, Fajardo LF. Radiation injury in surgical pathology. Part II. Alimentary tract. Am J Surg Pathol. 1981;5(2):153-78. DOI:10.1097/00000478-198103000-00006
51. Larsen A, Bjørge B, Klementsen B, et al. Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. Acta Oncol. 2007;46(5):639-50. DOI:10.1080/02841860601099241
52. Haboubi NY, Kaftan SM, Schofield PF. Radiation colitis is another mimic of chronic inflammatory bowel disease. J Clin Pathol. 1992;45(3):272. DOI:10.1136/jcp.45.3.272-a
53. Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol. 2007;8(11):1007-17. DOI:10.1016/S1470-2045(07)70341-8
54. Burkovskaia VA. Radiatsionnye (luchevye) porazheniia kishechnika. Gastroenterologiia Sankt-Peterburga. 2013;3-4:18-24 (in Russian).
55. Andreyev HJ, Wotherspoon A, Denham JW, Hauer-Jensen M. “Pelvic radiation disease”: new understanding and new solutions for a new disease in the era of cancer survivorship. Scand J Gastroenterol. 2011;46(4):389-97. DOI:10.3109/00365521.2010.545832
56. Shadad AK, Sullivan FJ, Martin JD, Egan LJ. Gastrointestinal radiation injury: symptoms, risk factors and mechanisms. World J Gastroenterol. 2013;19(2):185-98. DOI:10.3748/wjg.v19.i2.185
57. Leiper K, Morris AI. Treatment of radiation proctitis. Clin Oncol (R Coll Radiol). 2007;19(9):724-9. DOI:10.1016/j.clon.2007.07.008
58. Vanneste BG, Van De Voorde L, de Ridder RJ, et al. Chronic radiation proctitis: tricks to prevent and treat. Int J Colorectal Dis. 2015;30(10):1293-303. DOI:10.1007/s00384-015-2289-4
59. Wu XR, Liu XL, Katz S, Shen B. Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis. Inflamm Bowel Dis. 2015;21(3):703-15. DOI:10.1097/MIB.0000000000000227
60. Gichangi P, Bwayo J, Estambale B, et al. HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer. Gynecol Oncol. 2006;100(2):405-11. DOI:10.1016/j.ygyno.2005.10.006
61. Mendelson RM, Nolan DJ. The radiological features of chronic radiation enteritis. Clin Radiol. 1985;36(2):141-8. DOI:10.1016/s0009-9260(85)80097-0
62. Son JH, Kim SH, Cho EY, Ryu KH. Comparison of diagnostic performance between 1 millisievert CT enterography and half-standard dose CT enterography for evaluating active inflammation in patients with Crohn's disease. Abdom Radiol (NY). 2018;43(7):1558-56. DOI:10.1007/s00261-017-1359-1
63. Algin O, Turkbey B, Ozmen E, Algin E. Magnetic resonance enterography findings of chronic radiation enteritis. Cancer Imaging. 2011;11(1):189-94. DOI:10.1102/1470-7330.2011.0026
64. Porouhan P, Farshchian N, Dayani M. Management of radiation-induced proctitis. J Family Med Prim Care. 2019;8(7):2173-18. DOI:10.4103/jfmpc.jfmpc_333_19
65. Kim HM, Kim YJ, Kim HJ, et al. A pilot study of capsule endoscopy for the diagnosis of radiation enteritis. Hepatogastroenterology. 2011;58(106):459-64.
66. Jazwinski A, Palazzo J, Kastenberg D. Capsule endoscopy diagnosis of radiation enteritis in a patient previously considered to have celiac sprue. Endoscopy. 2007;39(Suppl. 1):E66. DOI:10.1055/s-2006-944715
67. Lee DW, Poon AO, Chan AC. Diagnosis of small bowel radiation enteritis by capsule endoscopy. Hong Kong Med J. 2004;10(6):419-21.
68. Webb GJ, Brooke R, De Silva AN. Chronic radiation enteritis and malnutrition. J Dig Dis. 2013;14(7):350-7. DOI:10.1111/1751-2980.12061
69. Pasov VV, Kurpesheva AK. Oslozhneniia i povrezhdeniia organov i tkanei pri luchevoi terapii. In: Osnovy luchevoi diagnostiki i terapii: natsional'noe rukovodstvo. Pod red. SK Ternovoi. Moscow: GEOTAR-Media, 2012 (in Russian).
70. Pasov VV, Kurpesheva AK, Terekhov OV. Mestnye luchevye povrezhdeniia u onkologicheskikh bol'nykh (konservativnoe lechenie). In: Terapevticheskaia radiologiia. Pod red. AF Tsyba, IuS Mardynskogo. Moscow: Meditsinskaia kniga, 2010 (in Russian).
71. Kennedy GD, Heise CP. Radiation colitis and proctitis. Clin Colon Rectal Surg. 2007;20(1):64-72. DOI:10.1055/s-2007-970202
72. Ma TH, Yuan ZX, Zhong QH, et al. Formalin irrigation for hemorrhagic chronic radiation proctitis. World J Gastroenterol. 2015;21(12):3593-8. DOI:10.3748/wjg.v21.i12.3593
73. Manojlovic N, Babic D. Radiation-induced rectal ulcer – prognostic factors and medical treatment. Hepatogastroenterology. 2004;51(56):447-50.
74. Chun M, Kang S, Kil HJ, et al. Rectal bleeding and its management after irradiation for uterine cervical cancer. Int J Radiat Oncol Biol Phys. 2004;58(1):98-105. DOI:10.1016/s0360-3016(03)01395-6
75. Kochhar R, Patel F, Dhar A, et al. Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci. 1991;36(1):103-7. DOI:10.1007/BF01300096
76. Topchii TB, Sycheva IV, Rukhadze GO, et al. Luchevye proktity: posobie dlia vrachei. Moscow: Prima Print, 2019 (in Russian).
77. Demers M, Dagnault A, Desjardins J. A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin Nutr. 2014;33(5):761-7. DOI:10.1016/j.clnu.2013.10.015
78. Cui M, Xiao H, Li Y, et al. Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med. 2017;9(4):448-61. DOI:10.15252/emmm.201606932
79. Thackham JA, McElwain DL, Long RJ. The use of hyperbaric oxygen therapy to treat chronic wounds: A review. Wound Repair Regen. 2008;16(3):321-30. DOI:10.1111/j.1524-475X.2008.00372.x
80. Pasquier D, Hoelscher T, Schmutz J, et al. Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: a literature review. Radiother Oncol. 2004;72(1):1-13. DOI:10.1016/j.radonc.2004.04.005
81. Dalsania RM, Shah KP, Stotsky-Himelfarb E, et al. Management of Long-Term Toxicity From Pelvic Radiation Therapy. Am Soc Clin Oncol Educ Book. 2021;41:1-11. DOI:10.1200/EDBK_323525
82. Yang XF, Zheng MY, An LY, et al. Quality evaluation of guidelines for the diagnosis and treatment of radiation enteritis. Radiat Oncol. 2023;18(1):14. DOI:10.1186/s13014-023-02204-9
83. Girvent M, Carlson GL, Anderson I, et al. Intestinal failure after surgery for complicated radiation enteritis. Ann R Coll Surg Engl. 2000;82(3):198-201.
84. Regimbeau JM, Panis Y, Gouzi JL, et al. Operative and long term results after surgery for chronic radiation enteritis. Am J Surg. 2001;182(3):237-42. DOI:10.1016/s0002-9610(01)00705-x
85. Onodera H, Nagayama S, Mori A, et al. Reappraisal of surgical treatment for radiation enteritis. World J Surg. 2005;29(4):459-63. DOI:10.1007/s00268-004-7699-3
86. Lefevre JH, Amiot A, Joly F, et al. Risk of recurrence after surgery for chronic radiation enteritis. Br J Surg. 2011;98(12):1792-7. DOI:10.1002/bjs.7655
87. Wilmore DW, Robinson MK. Short bowel syndrome. World J Surg. 2000;24(12):1486-92. DOI:10.1007/s002680010266
88. Donohoe CL, Reynolds JV. Short bowel syndrome. Surgeon. 2010;8(5):270-9. DOI:10.1016/j.surge.2010.06.004
89. Nightingale J. Intestinal failure and short bowel syndrome. Medicine. 1998;26:114-6. DOI:10.1051/medsci/2021110
90. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124(4):1111-34. DOI:10.1016/s0016-5085(03)70064-x
91. Jang H, Park S, Lee J, et al. Rebamipide alleviates radiation-induced colitis through improvement of goblet cell differentiation in mice. J Gastroenterol Hepatol. 2018;33(4):878-86. DOI:10.1111/jgh.14021
92. Zvyaglova MYu, Knyazev OV, Parfenov AI. Pharmacological and clinical feature of rebamipide: new therapeutic targets. Terapevticheskii Arkhiv (Ter. Arkh.). 2020;92(2):104-11 (in Russian). DOI:10.26442/00403660.2020.02.000569
93. Simanenkov VI, Maev IV, Tkacheva ON, et al. Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus. Cardiovascular Therapy and Prevention. 2021;20(1):2758 (in Russian). DOI:10.15829/1728-8800-2021-2758
94. Jang H, Lee J, Park S, et al. Pravastatin Attenuates Acute Radiation-Induced Enteropathy and Improves Epithelial Cell Function. Front Pharmacol. 2018;9:1215. DOI:10.3389/fphar.2018.01215
95. Jang H, Kim S, Kim H, et al. Metformin Protects the Intestinal Barrier by Activating Goblet Cell Maturation and Epithelial Proliferation in Radiation-Induced Enteropathy. Int J Mol Sci. 2022;23(11):5929. DOI:10.3390/ijms23115929
96. Yang JY, Liu MJ, Lv L, et al. Metformin alleviates irradiation-induced intestinal injury by activation of FXR in intestinal epithelia. Front Microbiol. 2022;13:932294. DOI:10.3389/fmicb.2022.932294
97. Nutting CM, Convery DJ, Cosgrove VP, et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2000;48(3):649-56. DOI:10.1016/s0360-3016(00)00653-2
98 Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001;51(1):261-6. DOI:10.1016/s0360-3016(01)01664-9
99. Lawrie TA, Green JT, Beresford M, et al. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. Cochrane Database Syst Rev. 2018;1(1):CD012529. DOI:10.1002/14651858
100. Theis VS, Sripadam R, Ramani V, Lal S. Chronic radiation enteritis. Clin Oncol (R Coll Radiol). 2010;22(1):70-83. DOI:10.1016/j.clon.2009.10.003

А.И. Парфенов¹, Л.Х. Индейкина*^1,2, Е.А. Сабельникова^1,3, А.В. Леонтьев^1,4, А.А. Макарова<sup>1

1</sup>ГБУЗ «Московский клинический научно-практический центр им. А.С. Логинова» Департамента здравоохранения г. Москвы, Москва, Россия;
²ГБУ «Научно-исследовательский институт организации здравоохранения и медицинского менеджмента» Департамента здравоохранения г. Москвы, Москва, Россия;
³ФГБОУ ВО «Российский университет медицины» Минздрава России, Москва, Россия;
⁴НОЧУ ВО «Московский финансово-промышленный университет “Синергия”», Москва, Россия
*I.indeykina@mknc.ru

________________________________________________

Asfold I. Parfenov¹, Lilia Kh. Indejkina*^1,2, Elena A. Sabelnikova^1,3, Aleksandr V. Leontiev^1,4, Alina A. Makarova<sup>1

1</sup>Loginov Moscow Clinical Scientific Center, Moscow, Russia;
²Research Institute for Healthcare and Medical Management, Moscow, Russia;
³Russian University of Medicine, Moscow, Russia;
⁴Moscow University for Industry and Finance “Synergy”, Moscow, Russia
*I.indeykina@mknc.ru